Ozempic and Wegovy maker Novo Nordisk quieted Wall Street’s concerns with its fourth-quarter results and 2025 outlook.

Waymo, the self-driving taxi, is gaining popularity across the U.S. It's entering new markets in 2024 while it continues to ...

Novo's earnings results Wednesday differ from Eli Lilly's, whose stock slid on slower-than-expected sales of weight loss ...

Obesity drug maker Novo Nordisk forecast slower growth this year after Wegovy sales more than doubled in the final quarter of ...

In August, Waymo expanded its ride-hailing service into the San Francisco Peninsula, adding 10 square miles and venturing ...

When Rice reached her goal weight, she tried phasing out semaglutide (marketed as Wegovy for weight loss and ... a chronic disease and these medicines work by helping people manage their appetite ...

Some people take advantage of financing deals from the automaker when they want to buy a new car. Others go to outside ... primary sources to support their work. These include white papers ...

Weight loss jabs such as Wegovy may reduce risk of dementia by ... Known as GLP-1 receptor agonists, the drugs work by mimicking hormones that regulate appetite. The study also highlighted ...

Then, weight loss was noticed as a significant side-effect - and Ozempic and Wegovy became household names ... Trials are already under way, external to work out if this effect is real.

Having made waves the world over, revolutionary anti-obesity drugs Wegovy and Ozempic (manufactured ... But the way these drugs work, especially the GLP-1 pathway, is exciting.” ...